Advertisement
Home Blog Page 3552
The prevalence of hepatitis E virus is low in HIV-infected women and men

Hepatitis E Virus Rare Among HIV-Infected Population

0
Prevalence of HEV viremia three in 2,919 plasma samples from HIV-infected adults
For patients with knee osteoarthritis

Medial, Not Lateral, Femorotibial Cartilage Change Predictive of OA

0
Loss of medial femorotibial cartilage thickness linked to radiographic and pain progression
Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase-positive non-small-cell lung cancer

FDA Approves Alecensa for ALK-Positive NSCLC

0
Drug is designed to block the effects of the ALK protein
Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

0
For overdose of the chemo drugs fluorouracil and capecitabine
People with asthma may be more than twice as likely to develop chronic migraines as those without asthma

Asthma Tied to Increased Risk of Chronic Migraines

0
Researchers suggest asthma is stronger predictor of chronic migraines than depression
Laser ablation may be an effective way to treat small breast cancers

SABCS: Laser Ablation May Be an Alternative Breast Cancer Tx

0
Procedure shows promise on tumors up to 2 cm in diameter, but more study is needed
Postmenopausal women with hormone receptor-positive ductal carcinoma in situ have similar recurrence rates of disease whether they take tamoxifen or the aromatase inhibitor anastrozole after surgery

SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

0
However, side effects differ for the two medications
For patients admitted with diagnoses of cirrhosis and ascites

Paracentesis Underutilized in Patients With Cirrhosis, Ascites

0
In-hospital mortality down with paracentesis use; trend toward reduction in mortality for early tx
For patients with non-small-cell lung cancer

Toxic Skin Effects Common With EGFR-TKI Use in NSCLC

0
Afatinib therapy linked to earlier paronychia onset; more dermatological visits for skin toxic effects
The prevalence of MITF p.E318K is similar in patients with melanoma

MITF p.E318K Prevalence Similar, Regardless of CDKN2A

0
Mutation correlates with increased risk, especially for multiple primary melanoma, high nevi count